| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |